# Legend Biotech Corp (LEGN)

Source page: https://stoqly.net/companies/legn

- **Ticker:** LEGN (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001801198
- **Latest annual report:** 20-F filed 2026-03-10 (https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $24.29 on 2026-11-09 (+3.80% on the day)
- **Market cap:** $4.5B
- **EPS, trailing 12 months:** −$1.62
- **Revenue (FY2025):** $1.0B
- **Revenue growth:** +64.0%
- **Revenue growth, 5-year CAGR:** +68.8%
- **Gross margin:** 61.4%
- **Operating margin:** −13.3%
- **Net margin:** −28.8%
- **Free cash flow:** −$129M
- **Free cash flow margin:** −12.5%
- **Return on invested capital:** −25.7%
- **Return on equity:** −29.1%
- **Net debt:** −$583M
- **Change in share count:** +0.8%
- **Piotroski F-score:** 2/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.3M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/legn/figures.csv

| US$ millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 49 | 60 | 75 | 69 | 117 | 285 | 627 | 1,029 |
| Operating income | — | — | — | — | — | -528 | -310 | -137 |
| Net income | -3 | -102 | -266 | -404 | -446 | -518 | -177 | -297 |
| Diluted EPS (US$) | -0.02 | -1.02 | -2.26 | -2.86 | -2.80 | -2.94 | -0.96 | -1.62 |
| Operating cash flow | 308 | -83 | -223 | -198 | -201 | -393 | -144 | -100 |
| Free cash flow | 287 | -110 | -249 | -241 | -222 | -413 | -158 | -129 |
| Cash | 210 | 83 | 456 | 689 | 786 | 1,278 | 287 | 902 |
| Debt and leases | — | — | — | 120 | 250 | 250 | 250 | 319 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.